Uridine 5'-monophosphate
|
Basic information |
| Metabolite name | Uridine 5'-monophosphate |
 | HMDB0000288 |
 |
C00105 |
 |
6030 |
| Synonyms | Uridine monophosphate; |
| No. of studies | 8 |
|
Basic information |
| Metabolite name | Uridine 5'-monophosphate |
| HMDB0000288 |
|
C00105 |
|
6030 |
| Synonyms | Uridine monophosphate; |
| No. of studies | 8 |
|
Relationship between Uridine 5'-monophosphate and depression (count: 8) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M050 | Type3 | 2h Ketamine group vs. control group | Hippocampus | C57BL/6 mouse | Up |
| Study M074 | Type1 | sCSDS group vs. control group | Faece | C57BL/6JJmsSlc mouse | Up |
| Study M1072 | Type1 | CUMS group vs. control group | Faece | Cynomolgus monkey | Up |
| Study M1091 | Type1 | CMS vulnerable group vs. control group | Ventral hippocampus | Wistar rat | Down |
| Study M1092 | Type1 | CMS group vs. control group | Ventral hippocampus | Wistar rat | Down |
| Study M1092 | Type3 | venlafaxine group vs. control group | Ventral hippocampus | Wistar rat | Down |
| Study M712 | Type1 | depression group vs. control group | Intestine | Cynomolgus monkey | Up |
| Study M885 | Type1 | CMS-vulnerable group vs. control group | Ventral hippocampus | Wistar rat | Up |
| Study M894 | Type2 | electromagnetic field exposure + heat acclimation group vs. electromagnetic field exposure group | Serum | C57BL/6J mouse | Down |